|By PR Newswire||
|July 31, 2014 02:30 PM EDT||
BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- Decision Resources Group's experts are scoping healthcare funding changes brought about by the Affordable Care Act (ACA), which has affected both reimbursement and prescribing of pharmaceutical therapies. The ACA altered how Managed Care Organizations (MCOs) cover beneficiaries through new regulations and expanded access via government-supported programs. Dynamic change is occurring in the health exchanges—state-based marketplaces set up by states or the federal government that allow individuals to shop for subsidized coverage—where benefit design and physician behavior result in an altered prescribing environment. A new Executive Briefing examines the key trends driven by the launch of health insurance exchanges and how they will impact the pharmaceutical industry over the next few years.
- Decision Resources Group's newest Executive Briefing, entitled Health Exchanges: What This New Channel Unlocks for Branded Agents, highlights the motivations of MCOs operating in the health insurance exchanges and outlines how their decisions affect prescribing and uptake.
- MCOs are increasingly participating in the exchanges. Some MCOs that sat out 2014, such as UnitedHealthcare, indicated they may be entering the market for 2015.
- MCOs are leveraging narrow networks. In a survey of 40 MCO pharmacy and medical directors that employ narrow networks, 65 percent cited the desire to reduce drug costs and 58 percent pointed to reducing medical costs as the key drivers.
- At least in the exchanges, the era of open formularies appears to be closing. In a recent survey of 44 MCOs that offer products on the exchange, fewer than half offered an open formulary—choosing instead either a closed, or partially closed, formulary.
- MCOs are placing higher out-of-pocket costs on exchange-based plans. Individuals covered by exchange-based plans are likely facing a deductible of at least $1,500. Surveyed plans with a deductible reported deductibles ranging from $1,600 to nearly $2,000 for an individual based on the value of the plan.
- Physicians will react to higher cost shares by prescribing lower cost drugs, hurting branded agents. With electronic health records systems and e-prescribing, physicians understand patient formularies better than before.
- To download the Executive Briefing, click here.
- Roy Moore, Principal Director at Decision Resources Group, comments: "Health insurance exchanges represent the biggest opportunity for the drug industry since the launch of Part D a decade ago, but this new market is not without challenges. Health plans' desire to control cost and utilization has resulted in new hurdles to access, which ultimately affect the actual drug prescribed. Drug firms must understand the intricacies of specific exchange-based plans to devise successful strategies that will work in this new channel."
About Physician & Payer Forum: Understand Healthcare Reform's Impact by Therapy
Decision Resources Group conducts primary research with physicians, MCO pharmacy directors and MCO medical directors—and leverages expert analysis—to find unique insights.
2014 coverage includes the following titles:
- Managed Care Strategies in Oncology: US Payer and Prescriber Insights on the Impact of Clinical Pathways, Bundled Payments, and ACOs on Brand Uptake in Renal Cell Carcinoma and Colorectal Cancer
- Healthcare Reform and Asthma: How Should Brand Marketers Adapt to the Launch of Exchanges and Expanded Medicaid?
- The Impact of ACOs on Prescribing for Acute Coronary Syndrome, Atrial Fibrillation, and Pulmonary Hypertension: Actionable Insights from US Payers and Prescribers
- High-Cost Biologics for Immune Diseases: How Will Healthcare Reform and Payer Led Cost-Taming Strategies Impact Brand Prescribing
- Population Health Management in Diabetes: What Does this Holy Grail of Practice Mean for Specific Diabetes Brands?
- Healthcare Reform and Mental Health: How Should Brand Marketers Adapt to the Launch of Exchanges and Expanded Medicaid?
Find out more about Physician & Payer Forum here.
About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Decision Resources Group
SOURCE Decision Resources Group
Oct. 1, 2016 11:30 AM EDT Reads: 1,322
Oct. 1, 2016 11:15 AM EDT Reads: 868
Oct. 1, 2016 10:45 AM EDT Reads: 602
Oct. 1, 2016 10:30 AM EDT Reads: 710
Oct. 1, 2016 10:30 AM EDT Reads: 1,724
Oct. 1, 2016 10:00 AM EDT Reads: 3,197
Oct. 1, 2016 10:00 AM EDT Reads: 605
Oct. 1, 2016 10:00 AM EDT Reads: 4,672
Oct. 1, 2016 10:00 AM EDT Reads: 519
Oct. 1, 2016 10:00 AM EDT Reads: 3,319
Oct. 1, 2016 09:45 AM EDT Reads: 2,769
Oct. 1, 2016 09:45 AM EDT Reads: 834
Oct. 1, 2016 09:15 AM EDT Reads: 1,677
Much of the value of DevOps comes from a (renewed) focus on measurement, sharing, and continuous feedback loops. In increasingly complex DevOps workflows and environments, and especially in larger, regulated, or more crystallized organizations, these core concepts become even more critical. In his session at @DevOpsSummit at 18th Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, showed how, by focusing on 'metrics that matter,' you can provide objective, transparent, and meaningful f...
Oct. 1, 2016 09:00 AM EDT Reads: 2,944